Back to News
Market Impact: 0.2
Fortrea Completes $45 Mln Acquisition Of Worldwide's Early Phase Services Divisions
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
Fortrea Holdings completed its $45 million all-cash acquisition of Worldwide Clinical Trials’ Early Phase Services division. The transaction expands Fortrea’s clinical research operations; the article provides no further financial terms or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
FTRE0.45
More News
- Australian data center operator NextDC's shares plunge 40% after it slashes earnings forecast
- Elon Musk says Tesla and SpaceX are weighing a $3.5 trillion merger—without him in the room
- Neoclouds Lose Silver Lining as Elice, CoreWeave Dive: Evening Briefing Americas
- Anthropic May Spend $750 Billion on Computing Costs, WSJ Reports
- This Janus Henderson fund manager owns CoreWeave debt — here's why he's sticking with it
- Super Micro’s stock soars after surprise update — with Dell and HPE shares joining the rally